Laurus Labs Shares Climb 4% After Q2 Profit Zooms 126% YoY

Laurus Labs shares climb 4% after Q2 profit zooms 126% YoY

Laurus Labs shares rose 3.79% to Rs 2,329 after the pharmaceutical company reported strong Q2FY27 results. Revenue increased 33% year-on-year to Rs 2,206 crore, while net profit more than doubled to Rs 441 crore. Growth was supported by sustained momentum in its CDMO business and Affordable Medicines division, alongside improving margins and continued investments in manufacturing capabilities.

Laurus Labs hits 52-week high as strong Q2 results fuel buying

Laurus Labs hits a 52-week high as Q2 gains, with sharp earnings growth and strategic acquisitions boosting investor optimism.

Laurus Labs Q2 net profit surges 126% backed by growth in CDMO, affordable medicines businesses

Laurus Labs Q2 FY27 net profit jumps 126% to ₹441 crore; revenue up 33% to ₹2,206 crore on strong CDMO and affordable medicines growth.

Laurus Labs Q2 results: Net profit jumps 126% on CDMO surge; buys Canadian firm to deepen oligonucleotide play

The Hyderabad-based drugmaker reported consolidated net profit of Rs 441 crore, up 126 percent from the year-ago period. Revenue rose 33 percent to Rs 2,206 crore

Laurus Labs hits 52-week high on reporting over two-fold jump in Q2 consolidated net profit

Mumbai, October 30 (Udaipur Kiran): Laurus Labs is currently trading at Rs. 2370.20, up by 125.20 points or 5.58% from its previous closing of Rs. 2245.00 on the… Laurus Labs hits 52-week high on reporting over two-fold jump in Q2 consolidated net profit